Sputum excretion of tubercle bacilli as early criterion in the evaluation of the therapeutic effectiveness of antituberculous drugs, illustrated by its use in a controlled trial of single-drug regimens.
D000284:Administration, Oral; D000328:Adult; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D009161:Mycobacterium / Q000302:isolation & purification; D010670:Phenylthiourea / Q000031:analogs & derivatives / Q000627:therapeutic use; D012146:Rest; D013183:Sputum / Q000382:microbiology*; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000382:microbiology*
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D010670:Phenylthiourea; D007538:Isoniazid